Trade Trend

In 2023, Ireland's total export value is 208.85Billion USD, total import value is 150.63Billion USD, Surplus is 58.22Billion USD, and foreign trade dependency is 0.659. In 2023，Ireland's top export products are Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) etc(44.38Billion USD), Heterocyclic compounds with nitrogen heteroatom(s) only(24.29Billion USD), Medicaments; (not goods of heading no. 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic use, put up in measured doses (incl. those in the form of transdermal admin. systems) or packed for retail sale(22.84Billion USD), top export destinations are United States(55.65Billion USD), United Kingdom(24.06Billion USD), Germany(22.01Billion USD). In 2023, Ireland's top import products are Aircraft n.e.c. in heading no. 8801, except unmanned aircraft of heading 8806, (e.g. helicopters, aeroplanes); spacecraft (including satellites) and suborbital and spacecraft launch vehicles(20.91Billion USD), Heterocyclic compounds with nitrogen heteroatom(s) only(17.61Billion USD), Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) etc(7.25Billion USD), top import origins are United Kingdom(29.03Billion USD), United States(24.03Billion USD), France(18.73Billion USD).

Comparing to 2022, Ireland's total export value decreased -5.31Billion USD(-2.48%) in 2023, this could result from its export decreases of products such as Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds(-6.65Billion USD or -60.90%), Electronic integrated circuits(-6.08Billion USD or -51.02%), Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) etc(-4.24Billion USD or -8.71%) and export decreases to countries/economics such as United States(-7.04Billion USD or -11.23%), Germany(-4.58Billion USD or -17.21%), China(-4.27Billion USD or -30.73%). Comparing to 2022, Ireland's total import value increased 3.36Billion USD(2.28%) in 2023, this could result from its import increases of products such as Aircraft n.e.c. in heading no. 8801, except unmanned aircraft of heading 8806, (e.g. helicopters, aeroplanes); spacecraft (including satellites) and suborbital and spacecraft launch vehicles(3.57Billion USD or 20.61%), Heterocyclic compounds with nitrogen heteroatom(s) only(3.19Billion USD or 22.13%), Medicaments; (not goods of heading no. 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic use, put up in measured doses (incl. those in the form of transdermal admin. systems) or packed for retail sale(1.77Billion USD or 50.35%), and its import increases from countries/economies such as France(4.49Billion USD or 31.55%), Switzerland(1.90Billion USD or 29.18%), United States(1.61Billion USD or 7.16%).

Cumulated to first 7 months of 2024, Ireland's total export value is 88.29Billion USD, total import value is 47.48Billion USD, and tradesurplus is 40.81Billion USD. Cumulated to first 7 months of 2024, Ireland's top export products are Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) etc(24.59Billion USD), Heterocyclic compounds with nitrogen heteroatom(s) only(9.02Billion USD), Medicaments; (not goods of heading no. 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic use, put up in measured doses (incl. those in the form of transdermal admin. systems) or packed for retail sale(8.92Billion USD), and top export destinations are United States(31.30Billion USD), Germany(8.05Billion USD), United Kingdom(7.84Billion USD). Cumulated to first 7 months of 2024, Ireland's top import products are Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) etc(24.59Billion USD), Heterocyclic compounds with nitrogen heteroatom(s) only(9.02Billion USD), Medicaments; (not goods of heading no. 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic use, put up in measured doses (incl. those in the form of transdermal admin. systems) or packed for retail sale(8.92Billion USD), and top import origins areUnited States(8.11Billion USD), United Kingdom(7.92Billion USD), France(5.13Billion USD).